Markets:

Overview

News

Currencies

International

Treasuries

Myovant Sciences Ltd. Common Shares (NY:MYOV)

N/A UNCHANGED

Last Price Updated: 7:00 PM EST, Mar 9, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Myovant Sciences Ltd. Common Shares

< Previous 1 2 3 4 5 Next >

Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022

January 26, 2023

From Myovant Sciences, Inc.

Via GlobeNewswire

MYOVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV

January 25, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08

November 16, 2022

From Myovant Sciences, Inc.

Via GlobeNewswire

Myovant Sciences: Q2 Earnings Insights ↗

October 26, 2022

Myovant Sciences (NYSE:MYOV) reported its Q2 earnings results on Wednesday, October 26, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Where Myovant Sciences Stands With Analysts ↗

October 25, 2022

Myovant Sciences (NYSE:MYOV) has observed the following analyst ratings within the last quarter:

Via Benzinga

Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources

November 16, 2022

From Myovant Sciences, Inc.

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Myovant Sciences Ltd. (NYSE - MYOV), ForgeRock, Inc. (NYSE - FORG), SeaSpine Holdings Corporation (Nasdaq - SPNE), LogicBio Therapeutics, Inc. (Nasdaq – LOGC),

October 31, 2022

From Brodsky & Smith LLC

Via GlobeNewswire

Looking Into Myovant Sciences's Return On Invested Capital ↗

October 28, 2022

Benzinga Pro data, Myovant Sciences (NYSE:MYOV) reported Q2 sales of $104.82 million. Earnings fell to a loss of $45.62 million, resulting in a 114.79% decrease from last quarter.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022 ↗

October 26, 2022

Upgrades

Via Benzinga

Myovant Sciences Announces Corporate Updates and Financial Results for Second Fiscal Quarter 2022

October 26, 2022

From Myovant Sciences, Inc.

Via GlobeNewswire

MYOVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV

October 25, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Earnings Outlook For Myovant Sciences ↗

October 25, 2022

Myovant Sciences (NYSE:MYOV) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that Myovant...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2022 ↗

October 25, 2022

Upgrades

Via Benzinga

US Stock Futures Down; Big Tech Earnings In Focus ↗

October 25, 2022

Pre-open movers U.S. stock futures traded lower in early pre-market trade on Tuesday after recording gains in the previous session. The Dow Jones jumped by more than 400 points on Monday after all the...

Via Benzinga

Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday ↗

October 25, 2022

Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) climbed 62.4% to close at $0.39. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation.

Via Benzinga

Avis Budget, Scholastic And Other Big Gainers From Monday ↗

October 25, 2022

U.S. stocks closed higher on Monday, with the Dow Jones gaining over 400 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Myovant Sciences Cancels Second Quarter Earnings Conference Call

October 24, 2022

From Myovant Sciences, Inc.

Via GlobeNewswire

Why Vaxcyte Shares Are Trading Sharply Higher? Here Are 63 Stocks Moving In Monday's Mid-Day Session ↗

October 24, 2022

Gainers Vaxcyte, Inc. (NASDAQ: PCVX) shares jumped 65% to $33.96 after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety,...

Via Benzinga

BYND Stock Alert: What to Know as Beyond Meat Launches Plant-Based Steak Product ↗

October 24, 2022

Beyond Meat (BYND) stock is on the move Monday after the company revealed Beyond Steak, a new plant-based steak product.

Via InvestorPlace

MYOV Stock Pops as Sumitomo Agrees to Buy Myovant Sciences ↗

October 24, 2022

Acquisition announcements can cause explosive share-price moves, and MYOV stock is spiking in the wake of a big-dollar buyout announcement.

Via InvestorPlace

US Stocks Mixed; Dow Jumps 200 Points ↗

October 24, 2022

U.S. stocks traded mixed this morning, with the Dow Jones surging around 200 points on Monday.

Via Benzinga

Why Myovant Sciences Stock Is Moving Higher ↗

October 24, 2022

Myovant Sciences Ltd (NYSE: MYOV) shares are trading higher Monday after the company announced it will be acquired by Sumitovant Biopharma for $27 per share in cash.

Via Benzinga

Tesla Slashes China EV Prices, TSMC Joins Embargo After NVIDIA and AMD, Schlumberger Rebrands As SLB: Top Stories Monday, Oct. 24 ↗

October 24, 2022

Benzinga

Via Benzinga

MYOV STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Myovant Sciences Ltd. Is Fair to Shareholders

October 24, 2022

From Halper Sadeh LLC

Via Business Wire

Myovant Sciences And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

October 24, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Why Soluna Holdings Shares Are Trading Sharply Lower; Here Are 38 Stocks Moving Premarket ↗

October 24, 2022

Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) rose 70.8% to $0.41 in pre-market trading. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation.

Via Benzinga

US Stock Futures Lower Following Friday's Rally; Tesla In Focus ↗

October 24, 2022

Pre-open movers U.S. stock futures traded lower in early pre-market trade on Monday after recording sharp gains in the previous session. The Dow Jones jumped by around 750 points on Friday. All the...

Via Benzinga

Myovant Sciences, Discover Financial And 3 Stocks To Watch Heading Into Monday ↗

October 24, 2022

With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Myovant Agrees To Be Acquired By Sumitomo Pharma Unit In $1.7B Deal As Japanese Company Sweetens Bid ↗

October 24, 2022

Myovant Sciences, Inc. (NYSE: MYOV) announced late Sunday a deal to be acquired by Japanese pharmaceutical company Sumitomo Pharma Co., Ltd's (OTC: DNPUF) unit Sumitovant Biopharma.

Via Benzinga

Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement

October 23, 2022

From Myovant Sciences, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Myovant Sciences Ltd. Common Shares (NY:MYOV)

All News about Myovant Sciences Ltd. Common Shares

Starting at $3.75/week.

Subscribe Today